Last reviewed · How we verify
A Randomized, Double-blind, Placebo-controlled, Cross-over Clinical Trial to Investigate the Efficacy of Bragg Apple Cider Vinegar Supplement on Blood Glucose Control in a Healthy Adult Population
The goal of this clinical trial is to evaluate the efficacy of a Bragg ACV supplement on postprandial glucose excursion compared to a placebo following a standardized acute carbohydrate load. Participants will be asked to consume an apple cider vinegar supplement 10 minutes prior to a standardized meal.
Details
| Lead sponsor | Bragg Live Food Products |
|---|---|
| Phase | NA |
| Status | NOT_YET_RECRUITING |
| Enrolment | 24 |
| Start date | 2026-01 |
| Completion | 2026-02 |
Conditions
- Postprandial Glucose
- Blood Glucose Concentration
Interventions
- Bragg ACV Supplement
- Placebo
Primary outcomes
- The difference in the incremental area under the curve (iAUC)(0 - 120 min) for venous blood glucose between Bragg ACV supplement and placebo following an acute carbohydrate load. — 0 and 120 minutes post dose
The difference in the incremental area under the curve (iAUC)(0 - 120 min) for venous blood glucose between Bragg ACV supplement and placebo following an acute carbohydrate load.
Countries
Canada